Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in HFpEF with Inflammation
NCT06604611Phase 4Not yet recruiting
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in heart failure with preserved ejection fraction (HFpEF). Planned start Oct 2024; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT06604611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06604611.